Hiromichi Ishiyama (H Ishiyama)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Radiation Therapy

Top Venues

Radiation oncology (London, England)

Japanese journal of radiology

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Kyohei Fujii, Masahiro Nakano, Shogo Kawakami, Yuichi Tanaka, Takuro Kainuma, Hideyasu Tsumura, Ken-Ichi Tabata, Takefumi Satoh, Masatsugu Iwamura, Hiromichi Ishiyama
Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients. Current oncology (Toronto, Ont.) 30 (5) (2023)
Hiroshi Onishi, Yoshiyuki Shioyama, Yasuo Matsumoto, Yukinori Matsuo, Akifumi Miyakawa, Hideomi Yamashita, Haruo Matsushita, Masahiko Aoki, Keiji Nihei, Tomoki Kimura, Hiromichi Ishiyama, Naoya Murakami, Kensei Nakata, Atsuya Takeda, Takashi Uno, Takuma Nomiya, Hiroshi Taguchi, Yuji Seo, Takafumi Komiyama, Kan Marino, Shinichi Aoki, Masaki Matsuda, Tomoko Akita, Masahide Saito
Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer. Cancers 15 (17) (2023)
Katsunori Yogo, Satoshi Kametaka, Hidetoshi Shimizu, Tomoki Kitagawa, Ryoichi Hirayama, Hiromichi Ishiyama, Hiroshi Yasuda, Seiichi Takami
Radiosensitization Effect of Gold Nanoparticles on Plasmid DNA Damage Induced by Therapeutic MV X-rays. Nanomaterials (Basel, Switzerland) 12 (5) (2022)
S Kawakami, H Tsumura, T Satoh, K Tabata, A Sekiguchi, T Kainuma, M Nakano, M Iwamura, Hiromichi Ishiyama
A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer. Radiation oncology (London, England) 17 (1) (2022)
Toyokazu Hayakawa, Ken-Ichi Tabata, Hideyasu Tsumura, Shogo Kawakami, Takeo Katakura, Masatoshi Hashimoto, Yusuke Watanabe, Masatsugu Iwamura, Tomoyuki Hasegawa, Hiromichi Ishiyama
Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients. Japanese journal of radiology 38 (10) (2020)
Toyokazu Hayakawa, Shogo Kawakami, Itaru Soda, Takuro Kainuma, Marika Nozawa, Akane Sekiguchi, Shunsuke Miyamoto, Taku Yamashita, Hiromichi Ishiyama
Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer. Radiation oncology (London, England) 14 (1) (2019)